The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference20 articles.
1. Clinical pharmacokinetics and pharmacodynamics of repaglinide;Hatorp;Clin Pharmacokinet,2002
2. Absorption, metabolism and excretion of a single oral dose of 14C-repaglinide during repaglinide multiple dosing;Van Heiningen;Eur J Clin Pharmacol,1999
3. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide;Bidstrup;Br J Clin Pharmacol,2003
4. Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes;Wang;Drug Metab Dispos,2002
5. Gemfibrozil greatly increases plasma concentrations of cerivastatin;Backman;Clin Pharmacol Ther,2002
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug–drug interactions explored within a PBPK framework;CPT: Pharmacometrics & Systems Pharmacology;2024-06-19
2. Design, synthesis and characterization of novel functional polyesters containing chromone curcumin units and evaluation of its anticancer potential-An in vitro and in silico approach;Journal of Saudi Chemical Society;2024-05
3. Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy;Chemico-Biological Interactions;2023-08
4. Effect of Myricetin on CYP2C8 Inhibition to Assess the Likelihood of Drug Interaction Using In Silico, In Vitro, and In Vivo Approaches;ACS Omega;2022-04-04
5. Efficacy and Cardiovascular Safety of Meglitinides;Current Drug Safety;2021-06-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3